[Skip to Content]
[Skip to Content Landing]
Comment & Response
April 26, 2016

TP53 Gene and Cancer Resistance in Elephants

Author Affiliations
  • 1Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(16):1789-1790. doi:10.1001/jama.2016.0446

To the Editor Dr Abegglen and colleagues1 confirmed a low cancer incidence in elephants and hypothesized that this relates to increased genomic protection by p53, possibly due to high copy numbers (20-40) of transcribed p53 pseudogenes. Also, peripheral lymphocytes and fibroblasts in elephants showed greater apoptotic sensitivity to ionizing radiation or doxorubicin than similar cells from humans.

First Page Preview View Large
First page PDF preview
First page PDF preview